Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Garden is a South Korean biotechnology company specializing in the production of high-value recombinant proteins using plant-based expression systems, a field known as molecular farming. The company utilizes its proprietary plant cell culture technology to manufacture growth factors such as EGF, bFGF, and VEGF for use in cosmeceuticals, wound healing, and regenerative medicine. By leveraging plants as bioreactors, Bio-Garden aims to provide a safer and more cost-effective alternative to traditional animal or microbial-based protein production. Their product portfolio primarily serves the high-end skincare and medical aesthetics markets, providing ingredients that promote skin regeneration and anti-aging. The company's platform technology allows for the production of human-like proteins with high purity and biological activity while minimizing the risk of pathogen contamination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Garden.